CI vs JNJ · P/E 2.4, rev $140.16B vs P/E 17, rev $49.37B
Cigna Corp (CI) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CI revenue for 2026-06-30 was $140.16B. Net income was $3.31B. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CI currently screens at market cap $71.62B and trailing P/E 2.4. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CI and JNJ stock pages for the full models.
Not investment advice.